#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	5634	16S	1529	1529	100.0	16S.l15.c4.ctg.1	1902	500.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1343	1343	C	587	C	341	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	10202	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3526	482.4	0	.	n	.	0	T695C	SNP	695	695	T	1118	1118	C	676	C,T	379,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	10202	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3526	482.4	0	.	n	.	0	G1337A	SNP	1337	1337	G	1760	1760	A	460	A	290	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	10202	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3526	482.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2394	2394	C	481	C	271	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	10202	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3526	482.4	1	SNP	n	A2045G	1	A2045G	SNP	2045	2045	A	2468	2468	G	541	G	306	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	10202	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3526	482.4	1	SNP	n	C2597T	0	.	.	2597	2597	C	3020	3020	C	528	C	310	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	27	47976	blaTEM	861	861	100.0	blaTEM.l15.c4.ctg.1	1361	5126.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Betalactam resistance
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	360	folP	855	855	99.88	folP.l15.c4.ctg.1	1457	43.9	1	SNP	p	R229S	1	.	.	685	687	AGC	929	931	AGC	59;60;60	A;G;C	36;36;37	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_G_01105	gyrA.WHO_G_01105	1	1	539	1132	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3272	61.0	0	.	p	.	0	D95A	NONSYN	283	285	GAC	573	575	GCC	73;75;75	G;C;C	40;42;44	.	.
gyrA.WHO_G_01105	gyrA.WHO_G_01105	1	1	539	1132	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3272	61.0	1	SNP	p	S91F	1	.	.	271	273	TTC	561	563	TTC	70;70;70	T;T;C	42;43;42	gyrA.WHO_G_01105:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	254	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1190	37.7	1	SNP	p	G45D	0	.	.	133	135	GGC	417	419	GGC	68;68;68	G;G;C	39;38;40	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	204	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	920	41.1	0	.	n	.	0	A197.	DEL	197	197	A	464	464	A	80	A	51	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	27	862	parC	2304	2304	99.83	parC.l15.c17.ctg.1	2860	51.6	1	SNP	p	D86N	0	.	.	256	258	GAC	638	640	GAC	71;71;73	G;A;C,T	41;38;40,1	parC.WHO_G_00206c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	27	862	parC	2304	2304	99.83	parC.l15.c17.ctg.1	2860	51.6	1	SNP	p	S87I	0	.	.	259	261	AGT	641	643	AGT	69;71;75	A;G;T	37;42;39	parC.WHO_G_00206c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	27	862	parC	2304	2304	99.83	parC.l15.c17.ctg.1	2860	51.6	1	SNP	p	S87W	0	.	.	259	261	AGT	641	643	AGT	69;71;75	A;G;T	37;42;39	parC.WHO_G_00206c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	27	862	parC	2304	2304	99.83	parC.l15.c17.ctg.1	2860	51.6	1	SNP	p	S87R	0	.	.	259	261	AGT	641	643	AGT	69;71;75	A;G;T	37;42;39	parC.WHO_G_00206c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	27	862	parC	2304	2304	99.83	parC.l15.c17.ctg.1	2860	51.6	1	SNP	p	S88P	0	.	.	262	264	TCC	644	646	TCC	75;75;75	T;C;C	42;43;44	parC.WHO_G_00206c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	766	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2944	47.1	0	.	p	.	0	P456S	NONSYN	1366	1368	CCC	1957	1959	TCC	48;48;48	T;C;C	30;31;31	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	766	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2944	47.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1819	1821	GGC	43;43;43	G;G;C	28;29;28	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.002	penA.2.002	1	1	27	924	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2065	73.6	1	SNP	p	A311V	0	.	.	931	933	GCA	1102	1104	GCA	89;89;89	G;C;A	50;53;54	penA.2.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	924	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2065	73.6	1	SNP	p	I312M	0	.	.	934	936	ATC	1105	1107	ATC	91;91;91	A;T,G;C	54;53,1;54	penA.2.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	924	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2065	73.6	1	SNP	p	V316P	0	.	.	946	948	GTG	1117	1119	GTG	89;89;89	G;T,G;G	53;50,1;52	penA.2.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	924	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2065	73.6	1	SNP	p	V316T	0	.	.	946	948	GTG	1117	1119	GTG	89;89;89	G;T,G;G	53;50,1;52	penA.2.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	924	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2065	73.6	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1621	1623	ACC	57;57;55	A;C;C	32;33;32	penA.2.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	924	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2065	73.6	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1675	1677	GCG	47;46;46	G;C,G;G	31;24,1;25	penA.2.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	924	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2065	73.6	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1675	1677	GCG	47;46;46	G;C,G;G	31;24,1;25	penA.2.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	924	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2065	73.6	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1798	1800	GGC	43;43;42	G,C;G;C	27,1;30;23	penA.2.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	924	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2065	73.6	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1807	1809	GGC	36;35;32	G;G;C	24;23;16	penA.2.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	924	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2065	73.6	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1825	1827	CCG	35;35;34	C;C;G	15;21;16	penA.2.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1798	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	2793	101.5	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1406	1408	CCG	64;66;66	C;C,T;G	32;37,1;38	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	570	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1841	51.6	0	.	p	.	0	S22G	NONSYN	64	66	AGC	523	525	GGC	71;71;71	G;G;C	41;40;39	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	570	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1841	51.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	705	705	C	44	C	23	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	614	porB1b	1047	1047	98.57	porB1b.l15.c4.ctg.1	1621	65.0	1	SNP	p	G120K	1	G120K	NONSYN	358	360	GGC	660	662	AAG	70;70;73	A;A;G	47;48;50	porB1b.WHO_P_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	614	porB1b	1047	1047	98.57	porB1b.l15.c4.ctg.1	1621	65.0	0	.	p	.	0	D121G	NONSYN	361	363	GAC	663	665	GGC	73;73;73	G;G;C	49;46;48	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	614	porB1b	1047	1047	98.57	porB1b.l15.c4.ctg.1	1621	65.0	0	.	p	.	0	E212D	NONSYN	634	636	GAA	936	938	GAT	145;145;145	G;A;T	88;89;87	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	614	porB1b	1047	1047	98.57	porB1b.l15.c4.ctg.1	1621	65.0	0	.	p	.	0	H213G	NONSYN	637	639	CAT	939	941	GGT	145;145;145	G;G;T,G	88;88;86,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	614	porB1b	1047	1047	98.57	porB1b.l15.c4.ctg.1	1621	65.0	0	.	p	.	0	V215A	NONSYN	643	645	GTT	945	947	GCT	148;148;148	G;C;T	90;87;91	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	614	porB1b	1047	1047	98.57	porB1b.l15.c4.ctg.1	1621	65.0	0	.	p	.	0	I218M	NONSYN	652	654	ATC	954	956	ATG	115;113;113	A;T,G;G	68;68,1;66	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	614	porB1b	1047	1047	98.57	porB1b.l15.c4.ctg.1	1621	65.0	0	.	p	.	0	R257T	NONSYN	769	771	AGG	1071	1073	ACG	97;96;96	A;C;G	57;56;56	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	614	porB1b	1047	1047	98.57	porB1b.l15.c4.ctg.1	1621	65.0	0	.	p	.	0	A259V	NONSYN	775	777	GCT	1077	1079	GTT	94;94;91	G;T;T,G	57;57;54,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	614	porB1b	1047	1047	98.57	porB1b.l15.c4.ctg.1	1621	65.0	0	.	p	.	0	D297N	NONSYN	889	891	GAC	1191	1193	AAC	66;66;68	A;A;C	42;42;43	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	2772	rpoB	4179	4179	99.95	rpoB.l15.c4.ctg.1	4536	103.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	226	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	859	47.0	1	SNP	p	V57M	1	.	.	169	171	ATG	447	449	ATG	85;87;92	A;T;G	45;47;49	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	27	8994	tetM	1920	1920	100.0	tetM.l6.c30.ctg.1	2552	561.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Tetracycline resistance
